According to The Insight Partners’ research, the global endoscopy device market is expected to reach US$ 45,612.3 million by 2025 from US$ 26,333.3 million in 2017, expanding at 7.5% CAGR over 2018–2025. Rising prevalence of diseases requiring endoscopy, favorable government initiatives, and technological advancements are attributed to this growth.

Increasing incidences of chronic rhinosinusitis (CRS) have driven the implementation of long-term medical management and functional endoscopic sinus surgery (FESS). Additionally, technological developments allow various market players to innovate technically advanced medical devices to treat CRS through minimally invasive procedures efficiently. Balloon sinuplasty is the widely used procedure to treat CRS, and various market leaders are developing balloon endoscopy device devices. With developments in balloon sinuplasty, various regulators are seen approving medical devices.

Rising environmental concerns such as climatic changes and pollution, and lifestyle changes are responsible for the growing number of chronic sinusitis cases. For instance, it is estimated that more than 135 million people in India have chronic sinusitis. Likewise, the incidences of sinus cancer in Germany are increasing. Increased chronic sinusitis cases will raise the need for surgical procedures, thus propelling global endoscopy device market expansion.

On the other hand, the risk of infections caused due to endoscopy are likely to hinder market expansion.

Based on product gamut, the global endoscopy device market is divided into endoscopes, visualization systems, other endoscopy equipment, and accessories. Among these, the endoscopes segment held 40.0% of the market share in 2017. The segment was valued at US$ 10,540.8 million in 2017 and is projected to reach US$ 18,810.5 million by 2025, growing at 7.9% CAGR over the forecast timeframe.